Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eloxatin, 5-Fluorouracil, and Leucovorin in Advanced Colorectal Carcinoma
NCT00004102Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Jan 1999
- Primary completion
- Nov 2001
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in colorectal cancer (CRC), sponsored by NYU Langone Health. Started Jan 1999; status: completed.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00004102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004102.